Amarin Corp Plc (AMRN)

[couldbebetter]

In large part I agree with your analysis. Given the negative propaganda by the likes of AF one must be prepared for a short-attack right after R-I results. Should BP be interested the sooner they strike the better for them. Should AMRN continue to go it alone they will issue more stock, but they could ramp up sales to around $2 billion. Assuming 3x revenues a market cap of $6 billion, with 600 million shares outstanding (yes, I'm adding 250 miion more shares) that would equate to $10.00 per share. From that point it would all depend on sales beyond $2 billion. Ultimately, I believe Vascepa could be an $8 billion in revenues drug with just 10% of the US statin users in 2020. (40 million patients x 10% = 4 million patients x $2000 a year = $8 billion. At such point a $24 billion market cap with maybe 600 milion shares outstanding one gets $40.00 a share. Keep in mind this is a very simple model with many flaws. (Some posters on this board have a habit of going into meltdown mode...hope they come back and contribute further to the board.)